Serum Prolactin Levels as an Intraindividual Biomarker for Guiding Osmotic-Release Oral System-Methylphenidate
Tsukasa Murata1, Maiko Nagaoka1,2, Masakatsu Sakamoto1
1Kumamoto Seimei Hospital, Kumamoto, Japan.
American Journal of Therapeutics
|March 17, 2026
Abstract
No abstract available in PubMed .
More Related Videos
08:56Author Spotlight: Automated Infusion and Blood Sampling for Precise Hormonal Analysis in Conscious Mice
Published on: August 25, 2023
2.7K
11:11Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning
Published on: February 17, 2016
12.5K
Related Concept Videos
Dosage Regimen: Multiple Oral Dosage
336
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...
336
Ophthalmic Drug Delivery Systems
173
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
173
Oral Drug Delivery Systems: Continuous-Release Systems
162
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
162
Therapeutic Drug Monitoring: Drug Analysis Methods
276
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
276
